Macrogenics Inc
MGNXNasdaqCIK 1125345HealthcareFiscal year ends Dec 31
Reports and events: 224 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2320:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-26-000066 |
| 2026-09-0320:39 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001125345-26-000059 |
| 2026-08-1420:19 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001125345-26-000056 |
| 2026-08-1320:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-26-000054 |
| 2026-07-2320:07 ET | 8-K | 8.01 Other events | 0001125345-26-000050 |
| 2026-07-0820:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001125345-26-000047 |
| 2026-07-0720:30 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001125345-26-000045 |
| 2026-05-2020:01 ET | 8-K | 5.07 Shareholder vote results | 0001125345-26-000042 |
| 2026-05-1320:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-26-000040 |
| 2026-05-1320:13 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001125345-26-000038 |
| 2026-05-1212:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001125345-26-000035 |
| 2026-05-0420:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-26-000032 |
| 2026-04-0820:41 ET | 8-K | 8.01 Other events | 0001125345-26-000026 |
| 2026-04-0820:01 ET | DEF 14A | Proxy statementPeriod 2026-05-19 | 0001125345-26-000021 |
| 2026-03-0920:12 ET | 8-K | 2.02 Results of operations | 0001125345-26-000018 |
| 2026-03-0920:10 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001125345-26-000017 |
| 2026-03-0221:15 ET | 8-K | 8.01 Other events | 0001125345-26-000011 |
| 2026-02-2423:41 ET | 8-K | 8.01 Other events | 0001125345-26-000009 |
| 2025-11-2021:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001125345-25-000111 |
| 2025-11-1221:04 ET | 8-K | 2.02 Results of operations | 0001125345-25-000109 |
| 2025-11-1221:04 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001125345-25-000108 |
| 2025-08-1420:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001125345-25-000101 |
| 2025-08-1420:04 ET | 8-K | 2.02 Results of operations | 0001125345-25-000100 |
| 2025-08-1320:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001125345-25-000094 |
| 2025-06-1011:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-25-000087 |
| 2025-05-2220:00 ET | 8-K | 5.07 Shareholder vote results | 0001125345-25-000075 |
| 2025-05-1320:02 ET | 8-K | 2.02 Results of operations | 0001125345-25-000054 |
| 2025-05-1320:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001125345-25-000053 |
| 2025-04-1120:00 ET | DEF 14A | Proxy statementPeriod 2025-05-21 | 0001125345-25-000047 |
| 2025-03-2020:05 ET | 8-K | 2.02 Results of operations | 0001125345-25-000043 |
| 2025-03-2020:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001125345-25-000042 |
| 2025-02-2622:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-036898 |
| 2024-11-2121:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001125345-24-000165 |
| 2024-11-0521:03 ET | 8-K | 2.02 Results of operations | 0001125345-24-000161 |
| 2024-11-0521:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001125345-24-000160 |
| 2024-10-3011:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-247017 |
| 2024-09-1620:02 ET | 8-K | 8.01 Other events | 0001125345-24-000151 |
| 2024-08-0620:02 ET | 8-K | 2.02 Results of operations | 0001125345-24-000149 |
| 2024-08-0620:01 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001125345-24-000148 |
| 2024-07-3020:18 ET | 8-K | 8.01 Other events | 0001125345-24-000141 |
| 2024-07-3020:08 ET | 8-K | 8.01 Other events | 0001125345-24-000140 |
| 2024-05-2320:24 ET | 8-K | 5.07 Shareholder vote results | 0001125345-24-000124 |
| 2024-05-0920:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-24-000091 |
| 2024-05-0920:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-24-000090 |
| 2024-05-0920:02 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001125345-24-000088 |
| 2024-04-0820:31 ET | DEF 14A | Proxy statementPeriod 2024-05-21 | 0001125345-24-000076 |
| 2024-04-0321:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001125345-24-000065 |
| 2024-03-0721:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-24-000061 |
| 2024-03-0721:03 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001125345-24-000060 |
| 2023-11-0621:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001125345-23-000125 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.